Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, X-linked disease, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemophilia B, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder	Enrolling by invitation	Not stated	2026-06-15		NCT06285071

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Novo Nordisk A/S	181

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Hospital of the University of Occupational And Environmental Health Japan_Pediatrics	Kitakyusyu-shi, Fukuoka	Japan	2
Kagoshima City Hospital_Pediatrics	Kagoshima	Japan	2
Kyushu university hospital_Pediatrics	Fukuoka	Japan	1
Mutsu general hospital_Pediatrics	Aomori	Japan	2
Nanbu Medical Center & Children's Medical Center_Hematology and Oncology	Okinawa	Japan	1
Ogikubo Hospital_Blood Coagulation	Tokyo	Japan	2
Sapporo Tokushukai Hospital_Pediatrics	Hokkaido	Japan	1
St. Marianna University School of Medicine Hospital_Pediatrics	Kanagawa	Japan	4
Tokyo Medical University Hospital	Tokyo	Japan	23
University of the Ryukyus Hospital_Endocrinology and Metabolism, Hematology and Rheumatology	Okinawa	Japan	2